Format

Send to

Choose Destination
Rev Med Virol. 2017 Jan;27(1). doi: 10.1002/rmv.1908. Epub 2016 Oct 10.

Saffold virus, an emerging human cardiovirus.

Author information

1
Temasek Life Science Laboratory, 1 Research Link, National University of Singapore, Singapore, Republic of Singapore.
2
Critical Care Unit, Central Manchester Foundation NHS Trust, Manchester, UK.

Abstract

Saffold virus (SAFV) is an emerging human cardiovirus that has been shown to be ubiquitous. Initial studies of SAFV focused on respiratory and gastrointestinal infection; however, it has also recently been associated with diverse clinical symptoms including the endocrine, cardiovascular, and neurological systems. Given the systemic nature of SAFV, and its high prevalence, understanding its pathogenicity and clinical impact is of utmost importance. This comprehensive review highlights and discusses recent developments in epidemiology, human pathogenicity, animal, and molecular studies related to SAFV. It also provides detailed insights into the neuropathogenicity of SAFV. We argue that human studies have been confounded by coinfections and therefore require support from robust molecular and animal research. Thereby, we aim to provide foresight into further research to better understand this emerging virus.

KEYWORDS:

CNS; Saffold virus; animal model; neurotropic; pathogenicity

PMID:
27723176
DOI:
10.1002/rmv.1908
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center